维普中文期刊产品整合服务
215篇 您的检索式:作者名="MUHLESTEIN JB"
    题名 作者 年代 出处 被引量
1中国汉族人群冠心病候选基因变异及其临床关联的地域特征显示文摘目的探讨冠心病候选基因单核苷酸多态性在中国汉族人群中的地域分布特征。方法选择西安、十堰及宁波地区汉族人群中经冠状动脉造影证实的冠心病及正常对照为研究对象。采用苯酚-氯仿-异丙醇抽提外周血白细胞全基因组DNA,通过聚合酶链式反应(PCR)及限制性片段长度多态性(RFLP)结合测序方法确定候选基因单核苷酸多态性(SNP)。SNP位点选择ATP结合盒转运子(ABCA1-G596A),胆固醇酯转运蛋白(CETP-Taq1B),脂蛋白脂酶(LPL-HindⅢ及LPL-PvuⅡ)。结果入选西安、十堰及宁波三个地区中国汉族人群615例(西安、十堰及宁波地区分别220、209及186例),平均年龄(60±10)岁,男性占75.9%。西安地区人群糖尿病罹患率以及血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)及甘油三酯(TG)水平显著高于十堰及宁波地区人群(均P〈0.05),高密度脂蛋白胆固醇(HDL-C)水平显著低于后者[分别为(1.17±0.48)mmol/L,(1.25±0.33)mmol/L,(1.29±0.44)mmol/L,P=0.03];三个地区人群之间ABCA1-G596A及CETP-Taq1B基因型频率分布差异具有统计学意义(均P〈0.01),而LPL基因型频率基本一致(P〉0.05);4个SNP对三个地区人群TC及LDL-C影响差异无统计学意义。ABCA1-G596A基因变异均显著升高三个地区人群血浆HDL-C水平(P〈0.01),同时降低TG水平[西安:GG(2.4±1.3)mmol/L、GA(1.9±0.9)mmol/L、AA(1.6±0.8)mmol/L,P〈0.01;十堰:GG(2.1±1.0)mmol/L、GA(1.9±0.8)mmol/L、AA(1.8±0.7)mmol/L,P=0.03;宁波:GG(1.9±1.1)mmol/L、GA(1.8±0.9)mmol/L、AA(1.6±0.7)mmol/L,P=0.05];三个地区人群LPL-HindⅢ(+/+)基因型携带者血浆TG均水平显著高于(-/-)携带者[西安:+/+(2.2±1.0)mmol/L、-/-(1.6±0.7)mmol/L,P=0.01;十堰:+/+(2.1±0.7)mmol/L、-/-(1.7±0.6)mmol/L,P=0.01;宁波:+/+(1.8±1.0)mmol/L、-/-(1.4±0.5)mmol/L,P=0.1301],而对HDL-C的影响无统计学意义;CETP-Taq1B、LPL-HindⅢ及LPL-PvuⅡ基因变异对不同地区人群HDL-C及(或)TG的影响不尽一致。4个SNP对三个地区汉族人群冠心病发病的影响均无统计学意义。结论不同地域中国汉族人群冠心病危险因素(环境因素和遗传因素)存在一定异质性;候选基因SNP可预测冠心病中间表型,但对临床表型缺乏显著影响,此联系独立于地域因素。王胜煌 崔翰斌 王东琦 陈晓敏 张宏考 崔长琮 陈新义 刘新宏 张征 白锋 Muhlestein JB 2008中华心血管病杂志2008,36,1:5
2Infection with cklamydia pneumoniae accelerates the elevelopment of atherosclerosis and treatment with azithromycin prevents it in a rabbit model 显示文摘Muhlestein JB Anderson JL Hammond EH 1998Circulation1998,97,3:1
3C-reactive protein and angiographic coronary artery disease:independent and additive predictors of risk in subjects with angina显示文摘Zebrack JS Muhlestein JB Home BD 2002J Am Coll Cardiol2002,39,4:1
4Genotypes of the cytochrome P450 isoform, CYP2C9, and thevitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study显示文摘CARLQUIST JF HORNE BD MUHLESTEIN JB 2006Thromb Thrombolysis2006,22,3:1
5Chronic infection and coronary artery disease显示文摘Muhlestein JB Anderson JL 2003Cardiol Clin2003,21,3:1
6Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease 显示文摘Madsen TE Muhlestein JB Carlquist JF 2005Am J Nephrol2005,25,1:1
7Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention 显示文摘Muhlestein JB Anderson JL Home BD 2003Am Heart J2003,146,2:1
8Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for chlamydia pneumoniae: the azithronmcin in coronary artery disase: elinination of myocardial infection with chlamydia study显示文摘Anderson JL Muhlestein JB Carlquist J 1999Circulation1999,99,12:1
9Evaluation of C-reactive protein,an inflammation markers,and inflammation markers,and infectious serious serology as risk factors for coronary artery disease and myocardial infarction显示文摘Anderson JL Darlquist JF Muhlestein JB 1998J Am Coll Cardiol1998,32,5:1
10Greater pathogen burden but not elevated C-reactive protein increase the risk of clinical restenosis after percutaneous coronary intervention显示文摘 Muhlestein JB Strobe GG 2002Am Heart J2002,144,3:1
11C - creative protein, interleukin- 6,secretory phospholipase A2 group Ⅱ A and inter - cdllular adhesion molecule - 1 in the predition of late outcome events after acute coronary syndromes显示文摘Harford M Muhlestein JB Home BD 2007J Inter Med2007,262,5:1
12Evaluation of C reactive protein,an inflammation marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction显示文摘Anderson JL Carlquist JF Muhlestein JB 1998J Am Coll Cardiol1998,32,1:1
13Cytomegalovirus seropositivity and C-reactive protein have independent and combined predicative value for mortality in patients with angiographically demonstrated coronary artery disease显示文摘Muhlestein JB Horne BD Carlquist JF 2000Circulation2000,102,:1
14Evaluation of C-reactive protein, an inflammatory marker, and infectious serology asrisk factors for coronary artery disease and myocardial infarction 显示文摘Anderson JL Carlquist JF Muhlestein JB 1998JAm Coll Cardiol1998,32,1:1
15Genotypes of the eytochrome P450 isoform,CYP2C9,and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable dose:a prospective study显示文摘Carlquist JF Horne BD Muhlestein JB 0,,3:1
16Lipoprotein-associated phospholipase A2:a new biomarker for cardiovascular risk assessment and potential therapeutic target显示文摘Carlquist JF Muhlestein JB Anderson JL 2007Expert Rev Mol Diagn2007,7,5:1
17Toll-like receptor 4gene Asp299Gly polymorphism is associated with reductions in vascular inflammation,angiographic coronary artery disease,and clinical diabetes显示文摘Kolek MJ Carlquist JF Muhlestein JB 2004Am Heart J2004,148,6:1
18Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality显示文摘Muhlestein JB Horne BD Bair TL 2001Am J Cardiol2001,87,:1
19Lack of association of Helicobacter pylori infection with coronary artery disease and fre- quency of acute myocardial infarction or death显示文摘Zhu J Quyyumi AA Muhlestein JB 2002Am J Cardiol2002,89,2:1
20Genotypes of the eytochrome P450 isoform,CYP2C9,and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable dose:a prospective study显示文摘Carlquist JF Home BD Muhlestein JB 2006Thromb Thrombolysis2006,22,3:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费